Service profile
Alzheon
Clinical-stage biopharmaceutical company developing oral small molecule therapies targeting amyloid precursor protein metabolism and synaptic function for Alzheimer's disease treatment.
About
What Alzheon is
Clinical-stage biopharmaceutical company developing oral small molecule therapies targeting amyloid precursor protein metabolism and synaptic function for Alzheimer's disease treatment.
losclouds keeps public details for this profile. There are no catalog offerings to compare yet.
EnterpriseHealthcare
At a glance
| Fact | Value |
|---|---|
| Official site | https://alzheon.com |
| Status coverage | Public status page |
| Founded | 2013 |
| Headquarters | Framingham, Massachusetts, United States |
| Categories | Enterprise, Healthcare |
Loading offerings...